Imprimis NJOF, LLC: 21 recalls on record

Recalls filed with 1 agency: FDA (21).

First recall on record: January 6, 2021. Most recent: January 14, 2026.

Risk classification: Class II: 14 · Class III: 7

Most recent recalls

DateAgencyProduct
January 14, 2026FDATri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular…D-0251-2026
January 14, 2026FDADexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraoc…D-0250-2026
January 14, 2026FDADexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, I…D-0249-2026
November 26, 2025FDAKlarity-C Drops (Cyclosporine) 0.1%, Preservative-Free Sterile Ophthalmic Emulsion, This …D-0157-2026
July 30, 2025FDATropicamide-Proparacaine-Phenylephrine-Ketorolac, Sterile Ophthalmic Solution, 1% 0.5% 2.…D-0536-2025
July 30, 2025FDAEpinephrine Lidocaine HCL, 0.25mg/mL and 7.5 mg/mL, 20x1 mL Vials per carton, Rx Only, Im…D-0535-2025
April 9, 2025FDATropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution, 1% 0.…D-0305-2025
June 19, 2024FDAKlarity-C (cyclosporine) Preservative-Free Sterile Ophthalmic Emulsion 0.1% 5.5mL, Rx Onl…D-0547-2024
June 19, 2024FDAPrednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension, 1%, 0.5%, 0.075%, 5mL,…D-0548-2024
June 5, 2024FDAEpinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vials…D-0512-2024
June 5, 2024FDAEpinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vial …D-0519-2024
June 5, 2024FDAMoxifloxacin 4 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular Injecti…D-0516-2024
June 5, 2024FDAMoxifloxacin 0.8 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular Injec…D-0515-2024
June 5, 2024FDADexamethasone-Moxifloxacin- Ketorolac (1mg/mL, 0.5 mg/mL and 0.4 mg/mL), Preservative-Fre…D-0514-2024
June 5, 2024FDADexamethasone-Moxifloxacin (1 mg/mL and 5mg/mL) Preservative-Free, 1mL Single-Use vials f…D-0513-2024
May 8, 2024FDAPrednisolone Sodium Phosphate-Moxifloxacin-Bromfenac Sterile Ophthalmic Solution 1%, 0.5%…D-0476-2024
May 8, 2024FDAEpinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free, 1 mL Single-Use vi…D-0478-2024
October 25, 2023FDAMYDRIATIC-4: Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic So…D-0043-2024
October 11, 2023FDAEpinephrine-Lidocaine HCl (0.25mg/mL and 7.5mg/mL) 1mL Single Use Intraocular injection P…D-0040-2024
August 30, 2023FDAMoxifloxacin - Bromfenac Sterile Ophthalmic Solution 0.5% / 0.075%, 5mL bottle, Imprimis …D-1094-2023
January 6, 2021FDADexamethasone - Moxifloxacin PF Injection (1/5) mg/mL, Imprimis Rx Volume: 1mL/vial, Impr…D-0177-2021

Questions about this company

How many recalls does Imprimis NJOF, LLC have?
Recalert has 21 U.S. recalls on record for Imprimis NJOF, LLC, published between January 6, 2021 and January 14, 2026.
What was the most recent Imprimis NJOF, LLC recall?
FDA recall D-0251-2026, published January 14, 2026: Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06.
Which agencies have handled Imprimis NJOF, LLC recalls?
Imprimis NJOF, LLC appears as the recalling firm in recalls from: FDA (21).

Do you carry products from Imprimis NJOF, LLC? Check your whole catalog free against 80,000+ recalls.

Paste up to 100 UPCs or SKUs and see which ones match a CPSC, FDA, NHTSA or FSIS recall. No account needed.

Check my catalog free

Want it checked every night instead? Starter watches 500 SKUs for $29/month. See plans

Related companies